Avadel Pharmaceuticals PLC
F:AWK
Avadel Pharmaceuticals PLC
F:AWK
Price:
18.1
EUR
Market Closed
Market Cap:
€1.8B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Avadel Pharmaceuticals PLC
F:AWK
|
IE |
| Metric | FY2015 | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| 173m | 150.2m | 173.2m | 103.3m | 59.2m | 22.3m | 0 | 0 | 28m | 169.1m | |
| (11.4m) | (13.2m) | (16.3m) | (17.5m) | (12.1m) | (5.7m) | 0 | — | (846k) | (15.3m) | |
| 161.6m | 137m | 156.9m | 85.8m | 47.1m | 16.6m | 0 | — | 27.1m | 153.8m | |
| (90.8m) | (142m) | (64.9m) | (123.6m) | (64.8m) | (56.6m) | (85.6m) | (95.2m) | (165m) | (196.2m) | |
| (21.7m) | (44.2m) | (58.9m) | (100.4m) | (30.2m) | (32.4m) | (68.5m) | (74.5m) | (151.7m) | (181m) | |
| (25.6m) | (34.6m) | (33.4m) | (39.3m) | (32.9m) | (20.4m) | (17.1m) | (20.7m) | (13.3m) | (15.2m) | |
| (12.6m) | (13.9m) | (3.7m) | (6.6m) | (816k) | (406k) | 0 | — | — | — | |
| (31m) | (49.3m) | 31m | 22.7m | (845k) | (3.3m) | 0 | — | — | — | |
| 70.8m | (5m) | 92m | (37.8m) | (17.7m) | (40m) | (85.6m) | (95.2m) | (137.8m) | (42.4m) | |
| 10.6m | 160k | (1.8m) | (10.6m) | (12.5m) | (13m) | (9.9m) | (12.3m) | (9.9m) | (10.8m) | |
| — | 963k | 1.1m | 10.6m | 12.5m | 13m | 9.9m | 12.3m | 9.9m | 10.8m | |
| 0 | 0 | (2.5m) | (67.1m) | (9.1m) | 45.8m | 53k | (3.3m) | (13.1m) | 0 | |
| (3.6m) | (4.9m) | 4.9m | 2.4m | 691k | 2.1m | 2.3m | (536k) | 87k | 4.2m | |
| 77.7m | (9.7m) | 92.7m | (113.2m) | (38.6m) | (5.1m) | (93.1m) | (111.4m) | (160.8m) | (49.1m) | |
| (35.9m) | (31.6m) | (27.9m) | 17.6m | 5.4m | 3m | 15.8m | (26m) | 501k | 247k | |
| 41.8m | (41.3m) | 64.8m | (95.6m) | (33.2m) | (2.1m) | (77.3m) | (137.5m) | (160.3m) | (48.8m) | |
| 41.8m | (41.3m) | 68.3m | (95.3m) | (33.2m) | 7m | (77.3m) | (137.5m) | (160.3m) | (48.8m) | |
| 0.96 | (1.00) | 1.63 | (2.56) | (0.89) | 0.12 | (1.32) | (2.29) | (2.00) | (0.51) |
A fast-growing oncology portfolio with volatile margins and cash conversion
A diversified healthcare platform pairing product-led growth with rising reinvestment
A large-scale generics platform funding an innovative-portfolio transition with recurring cash generation
A launch-driven pharmaceutical platform with rapidly expanding margins and cash generation
Continue AWK Research
Other Avadel Pharmaceuticals PLC listings:
